Upon completion of this educational activity, participants should be able to:
- Explain the latest data regarding diagnosis and treatment of various diseases affecting women;
- Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period; and
- Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women’s health.
Relias Learning designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Relias Learning is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians and nurses.
OB/GYN Clinical Alert’s editor, Jeffrey T. Jensen, MD, MPH, reports that he is a consultant for and receives grant/research support from Bayer, Abbvie, ContraMed, and Merck; he receives grant/research support from Medicines 360, Agile, and Teva; and he is a consultant for MicroChips and Evofem. Peer reviewer Catherine Leclair, MD, nurse planners Marci Messerle Forbes, RN, FNP, and Andrea O’Donnell, FNP; AHC Media editorial group manager Terrey L. Hatcher; executive editor Leslie Coplin; and editor Jonathan Springston report no financial relationships relevant to this field of study.